Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 1st GBHI-Conference – Conference Report now available 3rd GBHI conference – program is online Who is a healthy subject? German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Hypothalamic Adrenocortical Dry eye Oncological patients Good Clinical Practice Slit lamp microscopy Phase IIa trials Safety Non interventional Pulse oximetry plethysmography CDASH Macular Bioavailability Patch adhesion First in human IMPD Absorption Pituitary CDISC FIM Endpoint Monitoring Postmenopausal women Statistical Analysis Plan HRT Pharmacodynamic studies MCID CDSIC Quality Management System ICF Biopharmaceutics Local tolerability Data Management Plan TTS CRO Axis Transdermal therapeutic system Inhalatives Product development Uveitis Database Elpro Sequential designs ADAM Sensitisation trials Pharmacokintetics Drug Drug Interaction Referral system Allergy Pragmatism Dry powder inhaler Patients Recruitment rates Sample size estimation Experience Phase I Unit Clinical Monitoring Bioequivalence Biometrics SocraTec C&S Clinical trials US CFR 21 Part 11 Drug Food Interaction Early phase Highly variable drugs Auditing Cough Scientific expertise Eye disease IEC Sore throat Source Data Verification Data Validation Plan Copyright Informed Consent Procedure Ovulation inhibition ANVISA Glaucoma Contraception Clinical study Quality Assurance Inspection US FDA Centralised procedure CRF Quality DFI Patient recruitment EMA Expert Standardisation Dose linearity Legal Information FDA Scientific advice Central surveillance system Ophthalmology Ophthalmologist SDV Authorities Phase IV Protocol development Investigators brochure Children Subcontractor qualification Ophthalmological trials Intensive assessment station Phase III Metered dose inhaler Biosimilars Data management GLP Protocol DUS Healthy subjects Degeneration IB Legal representative Edema Biopharmaceutical GCP training Phase II Statistical programming MMM Xerostomia In vitro in vivo correlation Paediatricians WinNonlin COPD PASS CDM Audit OTC Project Management DDI IVIVC Pharmacology Life cycle management Creativity CRA Design development Patch Post authorisation DPI NIS Training Phase I Immunogenicity Common cold MDI SAS Oncologic network Thuringia GCP Pilot study Statistical services Spacious archive Absorption windows Phase IIb trials Competence Asthma Steady state Oncology Clinical pharmacology unit AGAH Lung Female adolescents Ocular tolerability Efficacy Feasibility Dermal irritation Standard operating procedure Cardiovascular surveillance Charcoal Hormone replacement therapy Clinical development program Network Consultancy PAES HPA axis HTA Gynaecological trials Rhine Main area Pharmacokinetics Anaesthesiologist SOP based  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page